Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, today officially enters the Nigerian market through an exclusive partnership with Pharaon Healthcare Nigeria (PHN). This strategic collaboration positions PHN as the sole distributor of Allergan Aesthetics’ science-based product portfolio across Nigeria, introducing a new era of advanced aesthetic solutions tailored to local needs.
Reflecting its dedication to Nigeria’s growing aesthetics sector, this partnership is set to deliver high-quality, proven aesthetic products and services to Nigerian consumers and healthcare professionals, offering a comprehensive portfolio designed for diverse skin types and aesthetic goals.
“We’re excited to bring Allergan Aesthetics’ innovative portfolio to Nigeria, a market with immense potential and a quality-conscious clientele,” said Michelle Nixon, Marketing Manager – South Africa & Sub Saharan Africa, Allergan Aesthetics. “Our exclusive partnership with Pharaon Healthcare Nigeria is a testament to our commitment to this region. We believe in empowering individuals to live as their truest, most authentic selves, supported by trusted, science-based solutions.”
“This exclusive distributorship marks a significant milestone for Nigeria’s aesthetics and healthcare sector,” added Anwar El Homsy, Regional Sales Manager at Pharaon Healthcare Africa (PHA). “As the sole partner of Allergan Aesthetics in Nigeria, PHN, the local entity of PHA, is positioned to elevate patient care standards by equipping local professionals with the world’s best tools, education and training.”
Allergan Aesthetics’ commitment to the ‘Journey to Individuality’ is central to its global mission. The brand offers a diverse portfolio of facial injectables – designed to enable personalised treatment plans and natural-looking results. In Nigeria, this will be reinforced with a strong focus on training and education, providing healthcare professionals access to global expertise, safety protocols and the latest techniques in aesthetic medicine.
